HAGEMAN ROBERT JOHAN JOSEPH,DE WILDE MATTHEUS CORNELIS,GROENENDIJK MARTINE,KAMPHUIS PATRICK JOSEPH GERARDUS HENDRIKUS
申请号：
IN5524/CHENP/2013
公开号：
IN2013CN05524A
申请日:
2013.07.11
申请国别(地区):
IN
年份:
2014
代理人:
摘要：
Composition comprising at least two components more preferably at least three components more preferably at least four components selected from the group of (i) a nucleoside equivalent (ii) an ? 3 polyunsaturated fatty acid selected from the group of DHA DPA and EPA (iii) a vitamin B (iv) a phospholipid (v) an antioxidant and (vi) a choline with the proviso that at least component (i) or (iii) is present for use in the prevention or treatment of frailty in a mammal wherein frailty is determined by compliance with at least 2 criterions preferably 3 criterions selected from the group of muscle weakness excessive feelings of exhaustion or fatigue abnormally low physical activity slow or unsteady gait weight loss and neurological dysfunction.
